期刊文献+

Model for liver hardness using two-dimensional shear wave elastography,durometer,and preoperative biomarkers 被引量:1

下载PDF
导出
摘要 BACKGROUND Post-hepatectomy liver failure(PHLF)increases morbidity and mortality after liver resection for patients with advanced liver fibrosis and cirrhosis.Preoperative liver stiffness using two-dimensional shear wave elastography(2D-SWE)is widely used to evaluate the degree of fibrosis.However,the 2D-SWE results were not accurate.A durometer measures hardness by quantifying the ability of a material to locally resist the intrusion of hard objects into its surface.However,the durometer score can only be obtained during surgery.To measure correlations among 2D-SWE,palpation by surgeons,and durometermeasured objective liver hardness and to construct a liver hardness regression model.METHODS We enrolled 74 hepatectomy patients with liver hardness in a derivation cohort.Tactile-based liver hardness scores(0-100)were determined through palpation of the liver tissue by surgeons.Additionally,liver hardness was measured using a durometer.Correlation coefficients for durometer-measured hardness and preoperative parameters were calculated.Multiple linear regression models were constructed to select the best predictive durometer scale.Receiver operating characteristic(ROC)curves and univariate and multivariate analyses were used to calculate the best model’s prediction of PHLF and risk factors for PHLF,respectively.A separate validation cohort(n=162)was used to evaluate the model.RESULTS The stiffness measured using 2D-SWE and palpation scale had good linear correlation with durometer-measured hardness(Pearson rank correlation coefficient 0.704 and 0.729,respectively,P<0.001).The best model for the durometer scale(hardness scale model)was based on stiffness,hepatitis B virus surface antigen,and albumin level and had an R2 value of 0.580.The area under the ROC for the durometer and hardness scale for PHLF prediction were 0.807(P=0.002)and 0.785(P=0.005),respectively.The optimal cutoff value of the durometer and hardness scale was 27.38(sensitivity=0.900,specificity=0.660)and 27.87(sensitivity=0.700,specificity=0.787),re
出处 《World Journal of Gastrointestinal Surgery》 SCIE 2021年第2期127-140,共14页 世界胃肠外科杂志(英文版)(电子版)
基金 National Natural Science Foundation of China,No.81372626 Key Research and Development Project of Science and Technology Department of Zhejiang,China,No.2015C03053 Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents.
  • 相关文献

参考文献4

二级参考文献100

  • 1Sheng, Qin-Song,Lang, Ren,He, Qiang,Yang, Yong-Jiu,Zhao, De-Fang,Chen, Da-Zhi.Indocyanine green clearance test and model for end-stage liver disease score of patients with liver cirrhosis[J].Hepatobiliary & Pancreatic Diseases International,2009,8(1):46-49. 被引量:37
  • 2Virginia Hernandez-Gea,Fanny Turon,Annalisa Berzigotti,Augusto Villanueva.Management of small hepatocellular carcinoma in cirrhosis:Focus on portal hypertension[J].World Journal of Gastroenterology,2013,19(8):1193-1199. 被引量:20
  • 3■ukasz Liszka,Ewa Zielińska-Paj■k,Jacek Paj■k,Dariusz Goka,Jacek Starzewski,Zbigniew Lorenc.Usefulness of two independent hist classifications of tumor regression iUsefulness of two independent histopathological classifications of tumor regression in patients with rectal cancer submitted to hyperfractionated pre-operative radiotherapy[J].World Journal of Gastroenterology,2007,13(4):515-524. 被引量:2
  • 4Patrick S. Kamath,Russell H. Wiesner,Michael Malinchoc,Walter Kremers,Terry M. Therneau,Catherine L. Kosberg,Gennaro D’Amico,E.Rolland Dickson,W.Ray Kim.A model to predict survival in patients with end-stage liver disease[J]. Hepatology . 2001 (2) 被引量:10
  • 5Chi-Leung Liu,Sheung-Tat Fan,Chung-Mau Lo,Yik Wong,Irene Oi-Lin Ng,Chi-Ming Lam,Ronnie Tung-Ping Poon,John Wong.Abdominal Drainage After Hepatic Resection Is Contraindicated in Patients With Chronic Liver Diseases[J]. Annals of Surgery . 2004 (2) 被引量:1
  • 6Roberto de Franchis.Revising consensus in portal hypertension: Report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension[J].Journal of Hepatology.2010(4) 被引量:15
  • 7John T. Mullen,Dario Ribero,Srinevas K. Reddy,Matteo Donadon,Daria Zorzi,Shiva Gautam,Eddie K. Abdalla,Steven A. Curley,Lorenzo Capussotti,Bryan M. Clary,Jean-Nicolas Vauthey.Hepatic Insufficiency and Mortality in 1,059 Noncirrhotic Patients Undergoing Major Hepatectomy[J].Journal of the American College of Surgeons.2007(5) 被引量:4
  • 8Wen-Tsan Chang,Wei-Yu Kao,Gar-Yang Chau,Chien-Wei Su,Hao-Jan Lei,Jaw-Ching Wu,Cheng-Yuan Hsia,Wing-Yiu Lui,Kuang-Liang King,Shou-Dong Lee.Hepatic resection can provide long-term survival of patients with non–early-stage hepatocellular carcinoma: Extending the Indication for resection?[J].Surgery.2012(5) 被引量:6
  • 9Yoshito Tomimaru,Hidetoshi Eguchi,Shigeru Marubashi,Hiroshi Wada,Shogo Kobayashi,Masahiro Tanemura,Koji Umeshita,Yuichiro Doki,Masaki Mori,Hiroaki Nagano.Equivalent Outcomes After Anatomical and Non-anatomical Resection of Small Hepatocellular Carcinoma in Patients with Preserved Liver Function[J].Digestive Diseases and Sciences.2012(7) 被引量:2
  • 10Divya Dahiya,Ting-Jung Wu,Chen-Fang Lee,Kun-Ming Chan,Wei-Chen Lee,Miin-Fun Chen.Minor versus major hepatic resection for small hepatocellular carcinoma (HCC) in cirrhotic patients: A 20-year experience[J].Surgery.2010(5) 被引量:2

共引文献61

同被引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部